Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

KAYCE SALA CINCAR

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1508422551
CMS profile
10944893
Location
ATLANTA, GA

General Payments · PY2021–2025

$12,633.09

  • Reported across 171 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$6,236.28

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
REVANCE THERAPEUTICS, INC. $5,747.81 23
ABBVIE INC. $436.14 9
Galderma Laboratories, L.P. $52.33 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $322.58 13
PY2022 $2,868.00 24
PY2023 $1,122.61 46
PY2024 $2,083.62 54
PY2025 $6,236.28 34

Payment records · PY2025 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2025 2021202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $93.17 03/10/2025 Food and Beverage Undisputed 06/30/2026 1203245412 CMS
ABBVIE INC. $7.81 04/29/2025 Food and Beverage Undisputed 06/30/2026 1203245418 CMS
ABBVIE INC. $18.53 06/25/2025 Food and Beverage Undisputed 06/30/2026 1203245425 CMS
ABBVIE INC. $17.38 08/07/2025 Food and Beverage Undisputed 06/30/2026 1203245431 CMS
ABBVIE INC. $116.40 09/14/2025 Food and Beverage Undisputed 06/30/2026 1203245437 CMS
ABBVIE INC. $134.75 09/17/2025 Food and Beverage Undisputed 06/30/2026 1203245443 CMS
ABBVIE INC. $20.00 10/07/2025 Food and Beverage Undisputed 06/30/2026 1203245449 CMS
ABBVIE INC. $7.91 10/16/2025 Food and Beverage Undisputed 06/30/2026 1203245454 CMS
ABBVIE INC. $20.19 12/18/2025 Food and Beverage Undisputed 06/30/2026 1203245461 CMS
Galderma Laboratories, L.P. $14.47 07/11/2025 Food and Beverage Undisputed 06/30/2026 1234743004 CMS
Galderma Laboratories, L.P. $37.86 09/24/2025 Food and Beverage Undisputed 06/30/2026 1234743006 CMS
REVANCE THERAPEUTICS, INC. $11.87 01/15/2025 Food and Beverage Undisputed 06/30/2026 1251180933 CMS
REVANCE THERAPEUTICS, INC. $8.85 02/19/2025 Food and Beverage Undisputed 06/30/2026 1251180935 CMS
REVANCE THERAPEUTICS, INC. $6.57 03/01/2025 Food and Beverage Undisputed 06/30/2026 1251180937 CMS
REVANCE THERAPEUTICS, INC. $5.54 03/17/2025 Food and Beverage Undisputed 06/30/2026 1251180939 CMS
REVANCE THERAPEUTICS, INC. $7.77 03/26/2025 Food and Beverage Undisputed 06/30/2026 1251180941 CMS
REVANCE THERAPEUTICS, INC. $107.14 04/01/2025 Food and Beverage Undisputed 06/30/2026 1251180943 CMS
REVANCE THERAPEUTICS, INC. $129.91 04/15/2025 Food and Beverage Undisputed 06/30/2026 1251180945 CMS
REVANCE THERAPEUTICS, INC. $19.64 04/23/2025 Food and Beverage Undisputed 06/30/2026 1251180947 CMS
REVANCE THERAPEUTICS, INC. $111.08 04/24/2025 Food and Beverage Undisputed 06/30/2026 1251180949 CMS
REVANCE THERAPEUTICS, INC. $110.21 05/08/2025 Food and Beverage Undisputed 06/30/2026 1251180951 CMS
REVANCE THERAPEUTICS, INC. $275.11 05/08/2025 Food and Beverage Undisputed 06/30/2026 1251180953 CMS
REVANCE THERAPEUTICS, INC. $43.10 07/26/2025 Food and Beverage Undisputed 06/30/2026 1251180955 CMS
REVANCE THERAPEUTICS, INC. $139.82 07/31/2025 Food and Beverage Undisputed 06/30/2026 1251180957 CMS
REVANCE THERAPEUTICS, INC. $25.21 07/31/2025 Food and Beverage Undisputed 06/30/2026 1251180959 CMS
REVANCE THERAPEUTICS, INC. $2,000.00 08/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1251180961 CMS
REVANCE THERAPEUTICS, INC. $12.50 09/19/2025 Food and Beverage Undisputed 06/30/2026 1251180963 CMS
REVANCE THERAPEUTICS, INC. $33.74 10/16/2025 Food and Beverage Undisputed 06/30/2026 1251180965 CMS
REVANCE THERAPEUTICS, INC. $134.46 10/16/2025 Food and Beverage Undisputed 06/30/2026 1251180967 CMS
REVANCE THERAPEUTICS, INC. $139.46 10/28/2025 Food and Beverage Undisputed 06/30/2026 1251180969 CMS
REVANCE THERAPEUTICS, INC. $375.00 11/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1251180971 CMS
REVANCE THERAPEUTICS, INC. $43.55 11/28/2025 Food and Beverage Undisputed 06/30/2026 1251180973 CMS
REVANCE THERAPEUTICS, INC. $7.28 12/01/2025 Food and Beverage Undisputed 06/30/2026 1251180975 CMS
REVANCE THERAPEUTICS, INC. $2,000.00 12/16/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 06/30/2026 1251180977 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.